 Christina Lisk
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Thalassemia | 2 | 2025 | 36 | 1.040 |
Why?
| | Anemia, Sickle Cell | 3 | 2025 | 269 | 0.990 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 32 | 0.230 |
Why?
| | Hemopexin | 1 | 2025 | 27 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 60 | 0.220 |
Why?
| | Heme | 1 | 2025 | 78 | 0.220 |
Why?
| | Iron | 2 | 2025 | 312 | 0.220 |
Why?
| | Hypertension, Pulmonary | 4 | 2025 | 1905 | 0.220 |
Why?
| | Hemoglobins | 2 | 2017 | 353 | 0.210 |
Why?
| | Proteomics | 3 | 2025 | 1109 | 0.200 |
Why?
| | Spleen | 1 | 2025 | 514 | 0.200 |
Why?
| | Exercise Tolerance | 1 | 2025 | 279 | 0.200 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 256 | 0.190 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 558 | 0.170 |
Why?
| | Monocytes | 1 | 2023 | 563 | 0.170 |
Why?
| | Proteome | 1 | 2025 | 472 | 0.170 |
Why?
| | Pulmonary Artery | 2 | 2017 | 1086 | 0.160 |
Why?
| | Lung | 2 | 2025 | 4063 | 0.140 |
Why?
| | Disease Progression | 2 | 2023 | 2751 | 0.140 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 32 | 0.130 |
Why?
| | Liver | 1 | 2025 | 1940 | 0.130 |
Why?
| | Mice | 5 | 2025 | 17759 | 0.120 |
Why?
| | Macrophages | 1 | 2023 | 1544 | 0.120 |
Why?
| | Haptoglobins | 1 | 2015 | 53 | 0.110 |
Why?
| | Chloride Channels | 1 | 2014 | 35 | 0.110 |
Why?
| | Altitude Sickness | 1 | 2014 | 153 | 0.100 |
Why?
| | Animals | 7 | 2025 | 36850 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4282 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 256 | 0.090 |
Why?
| | Oxidative Stress | 2 | 2025 | 1314 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5750 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2014 | 926 | 0.070 |
Why?
| | Heme Oxygenase-1 | 1 | 2025 | 64 | 0.060 |
Why?
| | Aerosols | 1 | 2025 | 176 | 0.050 |
Why?
| | Hemolysis | 1 | 2025 | 206 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 319 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 445 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2163 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 678 | 0.040 |
Why?
| | Erythrocytes | 1 | 2025 | 699 | 0.040 |
Why?
| | Humans | 5 | 2025 | 136803 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 2486 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 3009 | 0.040 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 20 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2017 | 153 | 0.030 |
Why?
| | Rats | 2 | 2015 | 5639 | 0.030 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2014 | 14 | 0.030 |
Why?
| | Acetazolamide | 1 | 2014 | 26 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1710 | 0.030 |
Why?
| | Tanzania | 1 | 2014 | 58 | 0.030 |
Why?
| | Mountaineering | 1 | 2014 | 40 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 139 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 145 | 0.030 |
Why?
| | Antiemetics | 1 | 2014 | 43 | 0.030 |
Why?
| | Commerce | 1 | 2014 | 77 | 0.030 |
Why?
| | Male | 5 | 2025 | 67330 | 0.030 |
Why?
| | Travel | 1 | 2014 | 130 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 87 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2015 | 372 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 409 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2015 | 190 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 778 | 0.020 |
Why?
| | Dexamethasone | 1 | 2014 | 368 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 846 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2015 | 243 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 278 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 391 | 0.020 |
Why?
| | Data Collection | 1 | 2014 | 668 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1059 | 0.020 |
Why?
| | Oxygen | 1 | 2014 | 930 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2476 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2838 | 0.020 |
Why?
| | Pneumonia | 1 | 2015 | 635 | 0.020 |
Why?
| | Lung Diseases | 1 | 2015 | 768 | 0.020 |
Why?
| | Hypoxia | 1 | 2015 | 1112 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4192 | 0.020 |
Why?
| | Female | 2 | 2017 | 72816 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 15510 | 0.010 |
Why?
|
|
Lisk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|